Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
09/2005
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005US20050209281 Salt formation by dissolving donepezil in ethanol, adding hydrogen chloride, forming polymorphic crystal; simplification; safety to environment and the bodies of operators; and can produce at low costs
09/22/2005US20050209279 Process for production of piperidine derivatives
09/22/2005US20050209278 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209222 Pharmaceutically active compounds and methods of use
09/22/2005DE102004010893A1 Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New ß-keto amide compounds with MCH-antagonistic effect and pharmaceutical compositions containing them
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2557904A1 Hiv integrase inhibitors
09/22/2005CA2557479A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1577298A1 Process for determining the purity of amlodipine
09/21/2005EP1575939A1 Novel compounds having selective inhibiting effect at gsk3
09/21/2005EP1575918A2 Substituted biaryl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575893A1 Process for the preparation of fexofenadine
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1278712B1 Nitroaromatic solubilizer for nitroxyls in aromatic solvents
09/21/2005CN1671664A Process for the preparation of stabilizers for polymers
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1219774C Non-sterioid inflammation-resisting compound
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946478 Compounds
09/20/2005US6946477 Analgesics; therapy for drug abruse
09/20/2005US6946475 Anticancer calcium channel blockers
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946269 Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2274946C Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
09/20/2005CA2188796C Heterocyclylbenzonitriles
09/15/2005WO2005085221A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/15/2005WO2005059037B1 Reagent for detecting an analyte
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005032479A3 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
09/15/2005WO2004112704A3 Substituted piperidine compounds and methods of their use
09/15/2005US20050203141 Polymorphic forms 2 and 3 of bilastin is transformed into polymorph 1, which is very stable and is not transformed into any of the other polymorphs 2 and 3; allergic reactions, pathological processes mediated by histamine
09/15/2005US20050203140 Paroxetine base, 1-methyl-3-hydroxymethyl-4-(4'-fluorophenyl)piperidine and paroxetine hydrochloride; chemical intermediates
09/15/2005US20050203139 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(4-[(4-hydroxybenzylamino)methyl]phenylcarbamoyl)ethyl)piperidin-4-yl ester
09/15/2005US20050203138 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203137 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-[2-((6-[2-(4-hydroxyphenyl)ethylamino]-hexanoyl)-methylamino)ethyl]piperidin-4-yl ester
09/15/2005US20050203136 Ifoxetine derivatives for psychiatric, psychological, eating, sexual, nervous system, seasonal affective, developmental, and bipolar disorders; antidepressants; anxiolytic, anticarcinogenic agents; dysthymia, menopause, neuropathic pain, irritable bowel syndrome, inflammatory bowel syndrome, autism
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203134 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-[4-(4-carbamoylpiperidin-1-ylmethyl)phenylcarbamoyl]ethyl)piperidin-4-yl ester
09/15/2005US20050203133 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203132 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203131 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203123 Substituted piperidine compounds and methods of their use
09/15/2005US20050203113 Compounds and method for the treatment of overactive bladder
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203083 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; e.g. Biphenyl-2-ylcarbamic acid 1-(2-[5-(4-hydroxybenzylamino)pentylcarbamoyl]ethyl)piperidin-4-yl ester; long duration of action; reduced side effects, such as dry-mouth and constipation
09/15/2005US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example
09/15/2005CA2555890A1 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
09/15/2005CA2552907A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/14/2005EP1572684A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572649A2 3-amino-piperidine derivatives and processes for their preparation
09/14/2005EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1572628A1 Isophtalic acid derivatives
09/14/2005EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
09/14/2005EP1289954B1 Serine protease inhibitors
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP1082307B1 Processes and intermediates for preparing 2-substituted piperidine stereoisomers
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668302A Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
09/14/2005CN1218941C Process for preparing ethyl-sulfonylpiperidine derivatives
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/13/2005US6943269 Contrast media for angiography
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943177 Alpha-lobeline analogs
09/13/2005US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/13/2005CA2210022C Paroxetine hydrochloride solvates
09/09/2005WO2005082852A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
09/09/2005WO2005058885A3 Piperidine derivatives and their use as glycine transporter inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005046611A3 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
09/09/2005WO2004108636A3 Isotopically labeled chemically stable reagents and process for the synthesis thereof
09/09/2005CA2554627A1 Immunosuppressant compounds and compositions
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 380